Vascular quality of care pilot study: how admission to a vascular surgery service affects evidence-based pharmacologic risk factor modification in patients with lower extremity peripheral arterial disease

BACKGROUND: Peripheral arterial disease (PAD) guidelines recommend aggressive risk factor modification to improve cardiovascular outcomes. Recommended pharmacologic therapies include antiplatelets, angiotensin converting enzyme (ACE) inhibitors, and HMG-CoA-reductase inhibitors (statins). PURPOSE: W...

Descripción completa

Detalles Bibliográficos
Autores principales: Steenhof, Naomi, Le Piane, Francesca, Leblanc, Kori, Eisenberg, Naomi R, Kwan, Yvonne, Malmberg, Christine, Papadopoulos, Alexandra, Roche-Nagle, Graham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4051795/
https://www.ncbi.nlm.nih.gov/pubmed/24940068
http://dx.doi.org/10.2147/VHRM.S61966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4051795/
https://www.ncbi.nlm.nih.gov/pubmed/24940068
http://dx.doi.org/10.2147/VHRM.S61966

Ejemplares similares